Johnson & Johnson to start trials of Covid vaccine in India
Johnson and Johnson will soon begin clinical trials of its single-shot Covid-19 vaccine in India, the company told Indian regulators.
In a letter to India’s Central Drugs Standard Control Organization (CDSCO), the U.S. based company said that it would “very shortly apply for permission to conduct clinical bridging trials in India,” reported Indian Express.
The report comes in as many vaccination centres in India suffer a shortage of vaccine supplies as the country of 1.3 billion is battling a second wave of Covid-19 infections that has eclipsed the first.
Recent Posts
India Reports Highest Tuberculosis Cases in 2024 Amid Progress in TB Control
India has recorded its highest-ever number of tuberculosis (TB) cases in 2024, with 26.07 lakh…
Elon Musk’s 120-Hour Workweek: The Dark Reality
Elon Musk is known for his relentless work ethic and high expectations from his teams.…
Patanjali’s Renogrit: A Breakthrough in Kidney Protection During Cancer Treatment
In 2024, a significant advancement in nephroprotection emerged from Patanjali Research Institute with the development…
Sunita Williams & Butch Wilmore’s 45-Day Rehab After Space Mission
NASA astronauts Sunita Williams and Barry "Butch" Wilmore have returned to Earth after an extended…
Bacterial Meningitis: The Silent Threat You Can’t Ignore
Bacterial meningitis is a life-threatening infection that leads to inflammation of the meninges, the protective…
Rare Human Coronavirus HKU1 Detected in Kolkata
A 45-year-old woman from Kolkata has been diagnosed with human coronavirus HKU1 (HCoV-HKU1), a rare…